Neuronetics (STIM)
(Delayed Data from NSDQ)
$4.25 USD
-0.30 (-6.60%)
Updated Aug 6, 2025 04:00 PM ET
Pre-Market: $4.04 -0.21 (-4.83%) 8:30 AM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Neuronetics, Inc. has a market cap of $280.70M, which represents its share price of $4.25 multiplied by its outstanding shares number of 66.13M. As a small-cap company, STIM's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
STIM 4.25 -0.30(-6.60%)
Will STIM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for STIM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STIM
Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
STIM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Integra LifeSciences (IART) Q1 Earnings Miss Estimates
Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet
BWAY Drops 15% in Four Days: How to Play the Stock Before Earnings?
Other News for STIM
Neuronetics (STIM) Price Target Reduced by Canaccord Analyst
Neuronetics price target lowered by $1 at Canaccord, here's why
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | STIM Stock News
Neuronetics (STIM): Canaccord Genuity Adjusts Price Target | STIM Stock News
Neuronetics Inc (STIM) Q2 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic Shifts